• Obesity is an increasing problem with rates continuing to rise • Treatment for OSAHS is poorly tolerated but surgical weight loss has good long-term results • Bariatric surgery has been shown to improve many of the comorbidities that are more prevalent in obesity, including improvement in daytime hypersomnolence and OSAHS What does the respiratory physician interested in sleep need to know about bariatric surgery?
What does the respiratory physician interested in sleep need to know about bariatric surgery?
Educational aims
 To understand the relationship between obstructive sleep apnoea/hypopnoea syndrome, obesity and bariatric surgery.
 To learn the mechanisms, techniques and non-respiratory benefi ts of bariatric surgery.
Summary
Obstructive sleep apnoea/hypopnoea syndrome (OSAHS) is reported to affect 4% of middle-aged males and 2% of middle-aged females in the UK [1] , with one of the most widely recognised major risk factors being obesity [2] . The prevalence of obesity in many countries is rising -in England, 24% of males and 24% of females were classified as obese in 2007 (body mass index (BMI) ≥30 kg per m 2 ), compared with 13.2% of males and 16.4% of females in 1993 [3] . The prevalence of OSAHS within the obese population is widely reported to range between 55-90% in people with a BMI of >40 kg per m 2 [4] , and many studies have found a reduction in the apnoea/hypopnoea index (AHI) and symptoms of OSAHS with weight loss [5] , although it is widely recognised that weight loss by medical methods does not yield good results in the long term. The mainstay of treatment for OSAHS is nocturnal continuous positive airway pressure (CPAP) therapy. This has been shown to have a discontinuation rate of 18-24% [2] , which adds to the need for alternative therapy for OSAHS associated with obesity. Bariatric surgery is the field of weight-loss surgery, from the Greek words 'baros' meaning 'weight' and 'iatrike' meaning 'medicine', and is widely accepted as the most effective, long-term treatment for obesity, especially in those with a BMI of >40 kg per m 2 . The Swedish Obese Subjects Trial, the largest trial studying surgical versus medical treatment of weight loss, showed an average weight loss of approximately 25.6% 2 yrs after surgery and 18.3% after 10 yrs, compared with a weight change of ±2% in the medically managed group [6] .
Entitlement
The UK National Institute for Health and Clinical Excellence (NICE), the US National Institutes for Health and the International Federation for the Surgery of Obesity guidelines advise that bariatric surgery should be considered as a treatment option in obese patients who fulfi l all of the following criteria [7] . 1) A BMI of >40 kg per m 2 and surgery. 5) The patients are committed to the need for long-term follow-up.
The NICE guidance also recommends bariatric surgery as a first-line option in patients with a BMI of >50 kg per m 2 in whom surgery is deemed appropriate.
2) All appropriate non-surgical measures have been tried but have failed to achieve or maintain adequate, clinically benefi cial weight loss for at least 6 months.
3) The patients have received or will receive intensive management in a specialist obesity service. 4) The patients are generally fi t for anaesthesia 
Techniques of bariatric surgery
Bariatric surgery works via many mechanisms, some of which are poorly understood. Historically it was separated into either restrictive or malabsorptive techniques, or a combination of both. However, there is probably no role played by malabsorption, as malabsorption of calories or proteins has not been shown to occur following most of the procedures. The most common procedure worldwide is the Roux-en-Y gastric bypass, which was initially developed in the 1960s. This procedure involves the formation of a small (<30 mL) stomach pouch that drains food into an alimentary or Roux limb (fi gure 1), whilst the remainder of the stomach secretes gastric acid, pepsin and intrinsic factor into a biliopancreatic limb which combines with pancreatic enzymes and bile and joins the alimentary (Roux) limb approximately 100 cm from the gastrojejunostomy. This procedure shortens the small intestine but still allows digestion and absorption. Roux-en-Y bypass works by reducing appetite in association with increased concentration of satiety gut hormones [8] . Sustained weight loss has been reported up to 16 yrs post-operatively with gastric bypass, and an average excess weight loss of 50-75% has been seen1-2 yrs post-operatively [9] , or a total weight loss of 25-30%. The second most common procedure is laparoscopic adjustable gastric banding (LAGB) (fi gure 2), which restricts the stomach by the placement of an adjustable band below the gastro-oesophageal junction, and the use of a port placed subcutaneously through which saline is injected allowing for adjustment of the band. The LAGB works by reducing hunger allowing patients to consume fewer calories per day. Other procedures include sleeve gastrectomy (fi gure 3), which has been shown to work through reduced hunger, increased speed of gastric emptying and alterations in gut hormones [10] . Procedures that do have a malabsorptive component include the biliopancreatic diversion and duodenal switch [11] . The advent of improved laparoscopic techniques in recent years has reduced post-operative pain, shortened hospital stays and decreased rates of wound infection and hernia formation [12] . 
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Bariatric surgery follow-up and post-operative polysomnography. A recent meta-analysis of 12 studies, representing 342 patients, investigating the effects of surgical weight loss on obstructive sleep apnoea (OSA) showed that bariatric surgery signifi cantly reduces the AHI but that the AHI after surgery was still consistent with moderate OSA, suggesting that patients undergoing bariatric surgery should not expect a cure for OSA after surgical weight loss [20] . However, several studies have recognised that daytime sleepiness is commonly associated with obesity in the absence of OSA or other sleepdisordered breathing [21, 22] ; therefore, improvement in obesity, as well as an improvement in AHI, may result in patients no longer meeting the diagnostic criteria for OSAHS. There have also been reports of recurrence of OSAHS in patients who have had bariatric surgery 7.5 yrs previously, without any increase in weight [23] , confi rming that although obesity is a major risk factor for OSAHS it is not the only risk factor.
Other studies into OSAHS and weight loss have shown a reduction in apnoeas and hypopnoeas in the order of 25% for every 10% of body weight lost [5] , which has been suggested to be due to reduction in mass loads in the airway from surrounding adipose tissue, restoration of the tracheal tug on pharyngeal tissues and improved neuromuscular control: all of which decrease the pressure needed to keep the airway open [24] . The same article also reports a reduction in CPAP pressure requirement seen after bariatric surgery, with a reduction in median pressure of 16 cmH 2 O at surgery to 8 cmH 2 O at 7-months follow-up [24] . In patients without underlying obesity hypoventilation or chronic obstructive pulmonary disease, the authors have suggested that autotitrating CPAP should, therefore, be used in bariatric patients post-operatively to allow for a reduction in CPAP pressure [24] .
Bariatric surgery and asthma
Interestingly, in obese patients with asthma several studies have shown that following bariatric surgery 90% of patients showed a reduction in symptoms of asthma 2 yrs after surgery, with 50% of patients having complete remission [25] . However, there is concern that the diagnosis of asthma may not be correct in some obese patients.
Conclusions
It is widely recognised that obesity is a risk factor for OSAHS and that OSAHS and obesity both
Complications in the OSAHS population
The complications of bariatric surgery differ depending on the nature of the procedure, but in one meta-analysis the overall mortality of all patients was found to be <0.3% [13] , which is similar to laparoscopic cholecystectomy. In patients undergoing bariatric surgery, those with OSAHS have an increased length of stay and higher cost for post-operative care [14] . Patients with OSAHS also have higher surgical risk due to worsening of obstructive events with anaesthetic and analgesic medications, as well as higher rates of post-operative cardiac arrhythmias, myocardial ischaemia, haemodynamic compromise and respiratory failure. These are most prevalent during the first 24 h after surgery [15] . The Longitudinal Assessment of Bariatric Surgery (LABS) consortium studied 4,776 patients who had undergone bariatric surgery (Roux-en-Y bypass or LAGB) and found a 30-day rate of death of 0.3%, with 4.3% of patients having one or more major adverse event. OSAHS, a previous history of deep vein thrombosis or pulmonary embolus, or impaired functional status were independent risk factors for death at 30 days [16] .
Non-respiratory benefi ts
Bariatric surgery aims to reduce the healthcare implications associated with obesity, whilst also having the added benefi t of improving quality of life and reducing overall medication costs for patients. Various meta-analyses have shown a reduction in morbidity from other conditions that are more prevalent in obesity, for example diabetes, hyperlipidaemia and hypertension [17] . A recent meta-analysis of bariatric surgery showed that out of 135,246 patients, those with diabetes had a resolution of diabetes of 78.1% and 86.6% had either resolution or improvement in diabetes [18] . An earlier meta-analysis by the same group showed [19] : 1) an improvement in hyperlipidaemia in ≥70% of patients; 2) resolution of hypertension in 62% and improvement in 79%; and 3) an improvement in symptoms of gastro-oesophageal refl ux disease.
Benefi ts in OSAHS
Many studies have reported an improvement in OSAHS following bariatric surgery, although most are small studies with a lack of long-term
Educational questions
Which statement is correct? lead to increased mortality and morbidity. Weight loss improves OSAHS, but is diffi cult to achieve and maintain by diet alone. Bariatric surgery is the most effective method of long-term weight loss and has been shown to improve OSAHS and reduce CPAP pressures, but is only available for patients fulfi lling certain criteria. Obese patients have been noted to suffer from daytime hypersomnolence in the absence of OSAHS, thus, an improvement in symptoms post-operatively is not always associated with an improvement in obstructive episodes at polysomnography. Further studies are warranted to assess this further and to assess the long-term morbidity associated with recurrent obstructive episodes in the absence of daytime symptoms. Randomised controlled trials are needed to compare bariatric surgery and best medical treatment in patients with OSAHS alone and, depending on these results, in the future bariatric surgery may be a treatment option for patients with OSAHS and a BMI <35 kg per m 2 if further trials show benefi t.
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